Evaluation of publicly available in vitro drug sensitivity models for ovarian and uterine cancer. Kimble DC, Dvergsten E, Thomeas-McEwing V, Karovic S, et al. Gynecol Oncol 2020 Nov 12. pii: S0090-8258(20)34066.

Read + Share

Amedeo Smart

Independent Medical Education

Kimble DC, Dvergsten E, Thomeas-McEwing V, Karovic S, et al. Evaluation of publicly available in vitro drug sensitivity models for ovarian and uterine cancer. Gynecol Oncol 2020 Nov 12. pii: S0090-8258(20)34066.
PMID: 33190933